Article
Delayed booster dosing improves human antigen-specific Ig and B cell responses to the RH5.1/AS01<sub>B</sub> malaria vaccine
2022-04-27
Abstract excerpt
<h4>Background</h4> Antibodies are crucial for vaccine-mediated protection against many pathogens. Modifications to vaccine delivery that increase antibody magnitude, longevity, and/or quality are therefore of great interest for maximising efficacy. We have previously shown that a delayed fractional (DFx) dosing schedule (0-1-6mo) – using AS01 B -adjuvanted RH5.1 malaria antigen – substantially improves serum IgG...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d5315484-b193-515e-b9d6-200d657b4d91
- DOI
- 10.1101/2022.04.25.22274161
